Palliative chemotherapy with or without anti-EGFR therapy for de novo metastatic nasopharyngeal carcinoma: a propensity score-matching study

OBJECTIVE: We aimed to investigate the efficacy and safety of cetuximab (CTX) or nimotuzumab (NTZ) on the addition of palliative chemotherapy (PCT) in patients with de novo metastatic nasopharyngeal carcinoma (NPC). MATERIALS AND METHODS: From 2007 to 2016, 451 eligible patients with de novo metasta...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Xue-Song, Liang, Yu-Jing, Li, Xiao-Yun, Liu, Sai-Lan, Chen, Qiu-Yan, Tang, Lin-Quan, Mai, Hai-Qiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6751225/
https://www.ncbi.nlm.nih.gov/pubmed/31686783
http://dx.doi.org/10.2147/DDDT.S215190

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6751225/
https://www.ncbi.nlm.nih.gov/pubmed/31686783
http://dx.doi.org/10.2147/DDDT.S215190

Ejemplares similares